It’s hard to believe, but we have now closed the book on our first full quarter of publishing Xconomy San Francisco. It’s fair to say that a little over three months ago, Wade and I were a teensy bit fired up about this new opportunity to cover the world capital of innovation.
How are we doing? We know the readers are the ultimate judges. But given the breakneck pace of news on the web, we like to take a deep breath once a quarter for our own in-house review. Wade and I set the bar high in our launch manifesto, in which we wrote: “We are storytellers, not buzz-chasers. We will do real reporting, not drive-by rehashes of the day’s headlines. We seek to lead the pack, not mimic it.”
Now that I’ve had a chance to skim back through our work from the past three months, here’s my own personal take on the top 10 Bay Area tech stories from Wade, and my 10 favorite stories from the life sciences beat. These are the kind of stories we are here to tell, stories that break new ground or shed new light, that engage you in conversation, and that you really can’t find anywhere else.
The coolest part is we are just getting warmed up. If you have any suggestions on people, companies, ideas we should dig into next, you know where to find us: editors@xconomy.com.
Wade’s Top 10 tech stories from the past quarter:
Can #NewTwitter Swim Faster Than a Fail Whale?
Anybots, Y Combinator’s Housemate, Brings Remote-Controlled Robots to the White-Collar World
The Leaning Tower of Ping: How iTunes Could be Apple’s Undoing
The Wars Over Mafia Wars: Dissecting Digital Chocolate’s Case Against Zynga
In Seed Funding Race, AngelList Sorts the Junk From the Maybes
Why Facebook Place Will Make Foursquare Into a Footnote
How a MacGyver of the Semiconductor Industry Plans to Rescue Nanosys
Innovating Where Banks Won’t: Talking With Rich Aberman About Wepay’s Vision for Group Payments
Luke’s Top 10 Life Sciences Stories from the third quarter
AvidBiotics Creates Novel Proteins That Kill Bacteria on the Farm, In the Lab, In the Body
Nodality Nears Market With Technology to Get the Right Cancer Drug to the Right Patients
Plexxikon Shows How New Drug Hits Molecular Target for Deadly Skin Cancer
Siluria, Backed by Arch, Alloy & Kleiner Perkins, Seeks Cheaper, Cleaner Plastics
Life Tech, in Competitive Frenzy for Cheap DNA Sequencing, Buys Ion Torrent for $375M
Third Rock Ventures, VC Firm With Appetite for Audacious Biotech Ideas, Sets Up Shop in SF
Solazyme, Founded on “Delusional” Idea of Algae Biofuel, Stakes Claim as Industry’s First Mover
Kristina Burow, Arch’s Startup Builder in SF, Shows Eye for Big Ideas of Biotech, Cleantech
Gail Maderis, the Boston Biotech Exec Who Came Home to SF, Seeks to Give Back at BayBio
Phylotech, Corey Goodman’s First Environmental Health Startup, Raises $1.2M in Seed Capital
